Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastasis From Malignant Tumor of Prostate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00629057
What this trial is testing

A Safety Trial of MVA-BN®-PRO in Men With Androgen-Insensitive Prostate Cancer

Who this might be right for
Androgen-insensitive Prostate Cancer
Bavarian Nordic 24
Not applicableStudy completedNCT02613273
What this trial is testing

CHAMP: A Randomized Controlled Trial of High-intensity Aerobic and Resistance Exercise for Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
University of California, San Francisco 28
Early research (Phase 1)Study completedNCT01414283
What this trial is testing

Prostate-specific Membrane Antigen Antibody-Drug Conjugate in Subjects With Prostate Cancer

Who this might be right for
Prostate Cancer
Progenics Pharmaceuticals, Inc. 52
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07268794
What this trial is testing

CONVERT-HB1: Radical Prostatectomy After Systemic Therapy for High-volume Metastatic Hormone-sensitive Prostate Cancer

Who this might be right for
Metastatic Prostate CancerProstate Cancer (Adenocarcinoma)Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Fudan University 112
Post-approval studies (Phase 4)Ended earlyNCT01933022
What this trial is testing

A Study in Patients With Metastatic Prostate Cancer to Assess How the Drug Eligard®, Affects Certain Markers in Blood and Urine, Which Are Indicators for the Disease

Who this might be right for
Metastatic Prostate Cancer
Astellas Pharma Europe Ltd. 1
Testing effectiveness (Phase 2)Study completedNCT01431391
What this trial is testing

Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer

Who this might be right for
Prostatic NeoplasmProstate CancerProstatic Adenocarcinoma
Dendreon 68
Not applicableEnded earlyNCT05437679
What this trial is testing

Characterization of Circulating Tumor Cells (CTCs) in High Risk and Early Metastatic Prostate Cancer Patients Using Parsortix® System

Who this might be right for
High Risk Prostate CarcinomaBiochemically Recurrent Prostate CarcinomaCastration-resistant Prostate Cancer+1 more
Angle plc 9
Testing effectiveness (Phase 2)Study completedNCT00072670
What this trial is testing

Trabectedin (Yondelis) in Adult Male Participants With Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 59
Not applicableNot Yet RecruitingNCT06718647
What this trial is testing

Efficacy and Tolerability of Low-Dose Enzalutamide in Prostate Cancer

Who this might be right for
Prostate Cancer Metastatic Disease
Monica Boitano 150
Testing effectiveness (Phase 2)Study completedNCT01341652
What this trial is testing

Phase II PAP Plus GM-CSF Versus GM-CSF Alone for Non-metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
University of Wisconsin, Madison 99
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06738745
What this trial is testing

Study of HRS-2189 Combined HRS-5041 in Prostate Cancer

Who this might be right for
Prostate Cancer Metastatic Disease
Fudan University 90
Very early researchNot Yet RecruitingNCT07674771
What this trial is testing

Response With Interim PSMA PET in Metastatic Castration-sensitive Prostate Cancer for Optimization of Adaptive Metastasis-directed Radiotherapy Delivery

Who this might be right for
Prostate CancerCastration Sensitive Prostate CancerMetastatic Prostate Cancer+1 more
University of Texas Southwestern Medical Center 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT04070209
What this trial is testing

Management of Oligoprogressive Castration Resistant Prostate Cancer (PCS X)

Who this might be right for
Metastatic Prostate CancerCastration-resistant Prostate Cancer
Sir Mortimer B. Davis - Jewish General Hospital 66
Testing effectiveness (Phase 2)Study completedNCT03652493
What this trial is testing

Trial Evaluating the Efficacy of CARBOPLATIN in Metastatic Prostate Cancer With Gene Alterations in the Homologous Recombination Pathway

Who this might be right for
Castration-resistant Prostate CancerMetastasis
Centre Francois Baclesse 16
Not applicableEnded earlyNCT02042053
What this trial is testing

PET/MR Assessment of Sipuleucel T Treatment for Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
NYU Langone Health 10
Not applicableNot Yet RecruitingNCT06136377
What this trial is testing

Evaluation of the Concordance Between Pre-therapy Dosimetry Performed From 68Ga-PSMA-11 Dynamic PET and Post-treatment Dosimetry of 177Lu-PSMA-617 Vectorized Internal Radiotherapy in Patients With Metastatic Prostate Cancer Resistant to Hormonal Castration.

Who this might be right for
Patients With Metastatic Castration-resistant Prostate Cancer
Centre Georges Francois Leclerc 35
Testing effectiveness (Phase 2)Study completedNCT00118092
What this trial is testing

17-AAG in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapy

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage IV Prostate Cancer
National Cancer Institute (NCI) 17
Large-scale testing (Phase 3)Active Not RecruitingNCT05288166
What this trial is testing

Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)

Who this might be right for
Prostatic NeoplasmsNeoplasm MetastasisUrogenital Neoplasms+14 more
Eli Lilly and Company 925
Early research (Phase 1)Looking for participantsNCT07096128
What this trial is testing

[177Lu] Lu-PSMA-XT Injection in Patients With Metastatic Prostate Cancer

Who this might be right for
mCRPC
Jinming Zhang 36
Testing effectiveness (Phase 2)Study completedNCT00049257
What this trial is testing

Paclitaxel and Carboplatin in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Who this might be right for
Prostate Cancer
Jonsson Comprehensive Cancer Center 58
Next Page